Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News Amara Raja Advanced Cell Technologies forms key partnership to boost India’s EV market Amara Raja Advanced Cell Technologies Pvt. Ltd (ARACT), a subsidiary of Amara Raja Energy & Mobility Ltd (ARE&M),… byPallavi MadhirajuJune 24, 2024